ENANTA PHARMACEUTICALS INC Annual Operating Lease, Payments in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Enanta Pharmaceuticals Inc annual/quarterly Operating Lease, Payments history and growth rate from 2020 to 2024.
  • Enanta Pharmaceuticals Inc Operating Lease, Payments for the quarter ending May 12, 2022 was $76.5K.
  • Enanta Pharmaceuticals Inc annual Operating Lease, Payments for 2024 was $8.28M, a 25.8% increase from 2023.
  • Enanta Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $6.59M, a 32.6% increase from 2022.
  • Enanta Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $4.97M, a 22% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.